Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.

相似書籍

• Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).
  由: Druce, MR, et al.
  出版: (2009)
• The Rapamycin Derivative RAD001 (Everolimus) Inhibits Cell Proliferation and Interacts with the Akt-mTOR-p70S6K Pathway in Human Medullary Thyroid Carcinoma Cells
  由: Grozinsky-Glasberg, S, et al.
  出版: (2009)
• The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells.
  由: Grozinsky-Glasberg, S, et al.
  出版: (2010)
• Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
  由: Dworakowska, D, et al.
  出版: (2009)
• mTOR Signalling, Nutrients and Disease
  由: Goberdhan, D, et al.
  出版: (2008)